New research has claimed that the herbal supplement Ginkgo biloba is "not worthwhile" as an Alzheimer's treatment.
According to a Press Association report, some one in ten people with dementia take the natural remedy in a bid to improve their concentration and memory.
However, a study funded by the Alzheimer's Society and conducted at Imperial College London has asserted that Ginkgo biloba has no benefits for Alzheimer's patients, adds the news provider.
This conclusion was based on a six-month study during which participants were given a daily 120 milligram dose of the supplement and compared to a control group.
It emerged that there were no significant improvements to the patients' lives following the experiment.
Speaking about the results, Professor Clive Ballard, director of research at the Alzheimer's Society, told the online news resource: "It's very disappointing that Ginkgo biloba does not benefit people with dementia."
Meanwhile, a new drug to treat Alzheimer's disease has shown encouraging results in trials.
According to Elan and Wyeth Pharmaceuticals, bapineuzumab had "statistically significant and clinically-meaningful benefits".
Please click here for help finding a nursing care home in the UK.